Serdal Korkmaz
Impact in
- Hematology top 10%
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Hematology 27
- Multiple Myeloma Research and Treatments 6
- Blood groups and transfusion 6
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 5
- Oncology 16
- Viral-associated cancers and disorders 4
- Co-authors
- Fevzi Altuntaş (26 shared papers)Mehmet Şencan (15 shared papers)Hatice Sebila Dökmetaş (4 shared papers)Özlem Yönem (3 shared papers)Sinem Namdaroğlu (11 shared papers)A. Uslu (4 shared papers)Mehmet Ali Erkurt (16 shared papers)Mehmet Sinan Dal (20 shared papers)
In The Last Decade
Serdal Korkmaz
55 papers receiving 605 citations
Peers
Comparison fields: 5 of 93
- Hematology 146
- Infectious Diseases 149
- Genetics 78
- Oncology 191
- Neurology 73
Countries citing papers authored by Serdal Korkmaz
This map shows the geographic impact of Serdal Korkmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serdal Korkmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serdal Korkmaz more than expected).
Fields of papers citing papers by Serdal Korkmaz
This network shows the impact of papers produced by Serdal Korkmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serdal Korkmaz. The network helps show where Serdal Korkmaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Serdal Korkmaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 84 | |
| 2 | 2006 | 76 | |
| 3 | 2013 | 76 | |
| 4 | 2015 | 39 | |
| 5 | 2013 | 37 | |
| 6 | 2018 | 28 | |
| 7 | 2020 | 25 | |
| 8 | 2020 | 24 | |
| 9 | 2013 | 21 | |
| 10 | 2021 | 14 | |
| 11 | 2017 | 13 | |
| 12 | 2014 | 12 | |
| 13 | 2020 | 11 | |
| 14 | 2012 | 11 | |
| 15 | 2015 | 9 | |
| 16 | 2016 | 9 | |
| 17 | 2013 | 9 | |
| 18 | 2010 | 9 | |
| 19 | 2021 | 8 | |
| 20 | 2021 | 7 |
About Serdal Korkmaz
Serdal Korkmaz is a scholar working on Hematology, Oncology, Genetics, Infectious Diseases and Surgery, having authored 63 papers that have together received 626 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Multiple Myeloma Research and Treatments (6 papers), Blood groups and transfusion (6 papers), Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Hematology (146 citations), Infectious Diseases (149 citations), Genetics (78 citations), Oncology (191 citations) and Neurology (73 citations). Serdal Korkmaz has collaborated with scholars based in Türkiye, Cambodia and Cyprus. Frequent co-authors include Fevzi Altuntaş, Mehmet Şencan, Hatice Sebila Dökmetaş, Özlem Yönem, Sinem Namdaroğlu, A. Uslu, Mehmet Ali Erkurt, Mehmet Sinan Dal, Soner Şenel and Tuğçe Nur Yiğenoğlu. Their work appears in journals such as Journal of Chemotherapy, Renal Failure, Journal of Clinical Apheresis, Hematological Oncology and Geriatrics and gerontology international.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.